Abstract 3143: Monitoring circulating tumor cell (CTC) and circulating tumor DNA (ctDNA) genomic alterations in ER positive (POS)/HER2 negative (NEG) advanced breast cancer during endocrine therapy: correlative study of AZD9496 oral SERD phase I trial
- Publication date
- 1 July 2021
- Publisher
- 'The Japanese Society of Strategies for Cancer Research and Therapy'